John needs little introduction to anyone in the critical care field, with a PhD in catecholamine physiology and a co-author / principle investigator on a number of practice changing papers including the CHEST and SAFE fluid trials.
John joins me to chat about his latest ground-breaking project, the PLUS trial (PlasmaLyte 148 versUs Saline) in ICU patients.
Listen to the podcast here : John Myburgh interview
No comments:
Post a Comment